Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Brain Diseases » Hypothalamic Diseases » Pituitary Diseases
Diseases [C] » Endocrine System Diseases [C19] » Pituitary Diseases
Description
Disorders involving either the ADENOHYPOPHYSIS or the NEUROHYPOPHYSIS. These diseases usually manifest as hypersecretion or hyposecretion of PITUITARY HORMONES. Neoplastic pituitary masses can also cause compression of the OPTIC CHIASM and other adjacent structures. MeSH
Hierarchy View
Subtype Terms (8)
Hypopituitarism
16 drugs (12 approved, 4 experimental)
Inappropriate ADH Syndrome
4 drugs (3 approved, 1 experimental)
Pituitary Neoplasms
43 drugs (33 approved, 10 experimental)
Phase 4 Indicated Drugs (2)
Phase 2 Indicated Drugs (3)
Other Experimental Indicated Drugs (3)
Organization Involved with Phase 4 Indications (15)
Organization Involved with Phase 2 Indications (19)
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (15)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
